MedTrace Logo

Exploring the Time Effect of Respiratory Muscle Training on the Pulmonary Function of Elderly People

NCT07042269 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-06-29

No results posted yet for this study

Summary

The goal of this clinical trial is to determine the effects of a 12-week respiratory muscle training (RMT) intervention on cardiopulmonary function and compare its efficacy with aerobic exercise in older adults. The main questions it aims to answer are:

* What are the effects of RMT compared to aerobic exercise on cardiopulmonary function?
* What is the minimal effective duration (temporal threshold) for observable physiological adaptations to RMT?
* To what extent are the training effects retained at 4-weeks post-intervention? Participants were randomly divided into RMT group and aerobic exercise group. The RMT group performed 12 weeks of progressive resistance training (initial, moderate, and high levels) using the Lung Fitness® breathing trainer, consisting of 10 breaths per set, 3 sets per session, twice daily (morning and evening), 5 days per week. The Aerobic Exercise group performed daily 10,000-step walking sessions 5 days per week, with exercise adherence assessed using the Exercise Adherence Questionnaire.

Conditions

  • Respiratory Muscle Training
  • Aerobic Exercise
  • Older Adults
  • Cardiopulmonary Function

Interventions

BEHAVIORAL

Aerobic Exercise

Performed daily 10,000-step walking (5 days/week)

BEHAVIORAL

Respiratory Muscle Training

Performed 12-week progressive resistance training using the Lung Fitness® breathing trainer (initial/moderate/high resistance levels)

Sponsors & Collaborators

  • Beijing Sport University

    lead OTHER

Principal Investigators

  • Mei Xue Li, Doctor · Beijing Sports University

  • Xu Guo, Master · Beijing Sports University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2022-07-01
Completion
2023-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07042269 on ClinicalTrials.gov